Temporal changes in cardiac force- and flow-generation capacity, loading conditions, and mechanical efficiency in streptozotocin-induced diabetic rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 294, Issue 2, 2008, Pages

  Yeih, Dong Feng ^a,b   Lin, Lian Yu ^b   Yeh, Hung I ^c   Lai, Yu Jun ^c   Chiang, Fu Tien ^b   Tseng, Chuen Den ^b   Chu, Shu Hsun ^a   Tseng, Yung Zu ^b,d  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Contractile function; Diabetes; Hemodynamics; Mechanical efficiency; Ventriculoarterial coupling

Indexed keywords

STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CURVE FITTING; DETERIORATION; DIABETES MELLITUS; HEART MUSCLE COMPLIANCE; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART PERFORMANCE; HEART STROKE VOLUME; HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SYSTOLIC DYSFUNCTION; SYSTOLIC HEART FAILURE;

ALGORITHMS; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CARDIAC OUTPUT; DIABETES MELLITUS, EXPERIMENTAL; ELASTICITY; HEART; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III; RATS; RATS, WISTAR; STROKE VOLUME; VASCULAR RESISTANCE; VENTRICULAR FUNCTION, LEFT;

EID: 39149097528     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00573.2007     Document Type: Article

References (52)

1. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 291: H1489-H1506, 2006.
2. Belke DD, Larsen TS, Gibbs EM, Severson DL. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab 279: E1104-E1113, 2000.
3. Campbell KB, Kirkpatrick RD, Knowlen GG, Ringo JA. Late-systolic pumping properties of the left ventricle. Deviation from elastance-resistance behavior. Circ Res 66: 218-233, 1990.
4. Campbell KB, Ringo JA, Knowlen GG, Kirkpatrick RD, Schmidt SL. Validation of optional elastance-resistance left ventricle pump models. Am J Physiol Heart Circ Physiol 251: H382-H397, 1986.
5. Carbonell LF, Salom MG, Garcia-Estan J, Salazar FJ, Ubeda M, Quesada T. Hemodynamic alterations in chronically conscious unrestrained diabetic rats. Am J Physiol Heart Circ Physiol 252: H900-H905, 1987.
6. Chang KC, Hsu KL, Tseng YZ. Effects of diabetes and gender on mechanical properties of the arterial system in rats: aortic impedance analysis. Exp Biol Med (Maywood) 228: 70-78, 2003.
7. Chang KC, Lo HM, Tseng YZ. Systolic elastance and resistance in the regulation of cardiac pumping function in early streptozotocin-diabetic rats. Exp Biol Med (Maywood) 227: 251-259, 2002.
8. Cheng X, Cheng XS, Kuo KH, Pang CC. Inhibition of iNOS augments cardiovascular action of noradrenaline in streptozotocin-induced diabetes. Cardiovasc Res 64: 298-307, 2004.
9. Cheng X, Xia Z, Leo JM, Pang CC. The effect of N-acetylcysteine on cardiac contractility to dobutamine in rats with streptozotocin-induced diabetes. Eur J Pharmacol 519: 118-126, 2005.
10. Cheng Y, George I, Yi GH, Reiken S, Gu A, Tao YK, Muraskin J, Qin S, He KL, Hay I, Yu K, Oz MC, Burkhoff D, Holmes J, Wang J. Bradycardic therapy improves left ventricular function and remodeling in dogs with coronary embolization-induced chronic heart failure. J Pharmacol Exp Ther 321: 469-476, 2007.
11. Garcia M, Moran A, Luisa Martin M, Barthelmebs M, San Roman L. The nitric oxide synthesis/pathway mediates the inhibitory serotoninergic responses of the pressor effect elicited by sympathetic stimulation in diabetic pithed rats. Eur J Pharmacol 537: 126-134, 2006.
12. Ghosh S, Qi D, An D, Pulinilkunnil T, Abrahani A, Kuo KH, Wambolt RB, Allard M, Innis SM, Rodrigues B. Brief episode of STZ-induced hyperglycemia produces cardiac abnormalities in rats fed a diet rich in n-6 PUFA. Am J Physiol Heart Circ Physiol 287: H2518-H2527, 2004.
13. Houben AJ, Schaper NC, Slaaf DW, Tangelder GJ, Nieuwenhuijzen Kruseman AC. Skin blood cell flux in insulin-dependent diabetic subjects in relation to retinopathy or incipient nephropathy. Eur J Clin Invest 22: 67-72, 1992.
14. How OJ, Aasum E, Kunnathu S, Severson DL, Myhre ES, Larsen TS. Influence of substrate supply on cardiac efficiency, as measured by pressure-volume analysis in ex vivo mouse hearts. Am J Physiol Heart Circ Physiol 288: H2979-H2985, 2005.
15. How OJ, Aasum E, Severson DL, Chan WY, Essop MF, Larsen TS. Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 55: 466-473, 2006.
16. Hunter WC, Janicki JS, Weber KT, Noordergraaf A. Systolic mechanical properties of the left ventricle. Effects of volume and contractile state. Circ Res 52: 319-327, 1983.
17. Ishihara H, Yokota M, Sobue T, Saito H. Relation between ventriculoarterial coupling and myocardial energetics in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 23: 406-416, 1994.
18. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 34: 29-34, 1974.
19. Kelly RP, Ting CT, Yang TM, Liu CP, Maughan WL, Chang MS, Kass DA. Effective arterial elastance as index of arterial vascular load in humans. Circulation 86: 513-521, 1992.
20. Kobayashi T, Matsumoto T, Ooishi K, Kamata K. Differential expression of alpha2D-adrenoceptor and eNOS in aortas from early and later stages of diabetes in Goto-Kakizaki rats. Am J Physiol Heart Circ Physiol 287: H135-H143, 2004.
21. Kubota T, Alexander J Jr, Itaya R, Todaka K, Sugimachi M, Sunagawa K, Nose Y, Takeshita A. Dynamic effects of carotid sinus baroreflex on ventriculoarterial coupling studied in anesthetized dogs. Circ Res 70: 1044-1053, 1992.
22. Lam CF, Peterson TE, Richardson DM, Croatt AJ, d'Uscio LV, Nath KA, Katusic ZS. Increased blood flow causes coordinated upregulation of arterial eNOS and biosynthesis of tetrahydrobiopterin. Am J Physiol Heart Circ Physiol 290: H786-H793, 2006.
23. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109: 120-124, 2004.
24. Litwin SE, Raya TE, Anderson PG, Daugherty S, Goldman S. Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle. J Clin Invest 86: 481-488, 1990.
25. Litwin SE, Raya TE, Daugherty S, Goldman S. Peripheral circulatory control of cardiac output in diabetic rats. Am J Physiol Heart Circ Physiol 261: H836-H842, 1991.
26. Mazumder PK, O'Neill BT, Roberts MW, Buchanan J, Yun UJ, Cooksey RC, Boudina S, Abel ED. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 53: 2366-2374, 2004.
27. f current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 109: 1674-1679, 2004.
28. Nagareddy PR, Xia Z, McNeill JH, MacLeod KM. Increased expression of iNOS is associated with endothelial dysfunction and impaired pressor responsiveness in streptozotocin-induced diabetes. Am J Physiol Heart Circ Physiol 289: H2144-H2152, 2005.
29. Nagatsu M, Spinale FG, Koide M, Tagawa H, DeFreitas G, Cooper Gt, Carabello BA. Bradycardia and the role of beta-blockade in the amelioration of left ventricular dysfunction. Circulation 101: 653-659, 2000.
30. Nichols CG, Hanck DA, Jewell BR. The Anrep effect: an intrinsic myocardial mechanism. Can J Physiol Pharmacol 66: 924-929, 1988.
31. Norby FL, Wold LE, Duan J, Hintz KK, Ren J. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am J Physiol Endocrinol Metab 283: E658-E666, 2002.
32. Poornima IG, Parikh P, Shannon RP. Diabetic cardiomyopathy: the search for a unifying hypothesis. Circ Res 98: 596-605, 2006.
33. Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR, Haider B. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 60: 884-899, 1977.
34. 34a. Sagawa K, Mauchan L, Suga H, Sunagawa K. Effects of growth and aging of organism on ESPVR: normalization of Ees for heart size. In: Cardiac Contraction and the Pressure-Volume Relationship. New York: Oxford, 1988, p. 352-353.
35. Schaffer SW, Tan BH, Wilson GL. Development of a cardiomyopathy in a model of noninsulin-dependent diabetes. Am J Physiol Heart Circ Physiol 248: H179-H185, 1985.
36. Shroff SG, Janicki JS, Weber KT. Evidence and quantitation of left ventricular systolic resistance. Am J Physiol Heart Circ Physiol 249: H358-H370, 1985.
37. Shroff SG, Motz W. Left ventricular systolic resistance in rats with hypertension and hypertrophy. Am J Physiol Heart Circ Physiol 257: H386-H394, 1989.
38. Shroff SG, Naegelen D, Clark WA. Relation between left ventricular systolic resistance and contractile rate processes. Am J Physiol Heart Circ Physiol 258: H381-H394, 1990.
39. Smith JM, Paulson DJ, Romano FD. Inhibition of nitric oxide synthase by L-NAME improves ventricular performance in streptozotocin-diabetic rats. J Mol Cell Cardiol 29: 2393-2402, 1997.
40. Suga H, Sagawa K. Instantaneous pressure-volume relationships and their ratio in the excised, supported canine left ventricle. Circ Res 35: 117-126, 1974.
41. Sunagawa K, Maughan WL, Burkhoff D, Sagawa K. Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol Heart Circ Physiol 245: H773-H780, 1983.
42. Sunagawa K, Sagawa K, Maughan WL. Ventricular interaction with the loading system. Ann Biomed Eng 12: 163-189, 1984.
43. Sunagawa K, Yamada A, Senda Y, Kikuchi Y, Nakamura M, Shibahara T, Nose Y. Estimation of the hydromotive source pressure from ejecting beats of the left ventricle. IEEE Trans Biomed Eng 27: 299-305, 1980.
44. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation 105: 1727-1733, 2002.
45. Takeuchi M, Igarashi Y, Tomimoto S, Odake M, Hayashi T, Tsukamoto T, Hata K, Takaoka H, Fukuzaki H. Single-beat estimation of the slope of the end-systolic pressure-volume relation in the human left ventricle. Circulation 83: 202-212, 1991.
46. 2+-ATPase improves myocardial contractility in diabetic cardiomyopathy. Diabetes 51: 1166-1171, 2002.
47. Vaartjes SR, Boom HB. Left ventricular internal resistance and unloaded ejection flow assessed from pressure-flow relations: a flow-clamp study on isolated rabbit hearts. Circ Res 60: 727-737, 1987.
48. Van den Bergh A, Flameng W, Herijgers P. Type II diabetic mice exhibit contractile dysfunction but maintain cardiac output by favourable loading conditions. Eur J Heart Fail 8: 777-783, 2006.
49. Westermann D, Rutschow S, Jager S, Linderer A, Anker S, Riad A, Unger T, Schultheiss HP, Pauschinger M, Tschope C. Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of Angiotensin type 1 receptor antagonism. Diabetes 56: 641-646, 2007.
50. 2+ cycling proteins, NADPH oxidase, poly(ADP-Ribose) polymerase and myosin heavy chain isozyme. Free Radic Biol Med 40: 1419-1429, 2006.
51. Yoon YS, Uchida S, Masuo O, Cejna M, Park JS, Gwon HC, Kirchmair R, Bahlman F, Walter D, Curry C, Hanley A, Isner JM, Losordo DW. Progressive attenuation of myocardial vascular endothelial growth factor expression is a seminal event in diabetic cardiomyopathy: restoration of microvascular homeostasis and recovery of cardiac function in diabetic cardiomyopathy after replenishment of local vascular endothelial growth factor. Circulation 111: 2073-2085, 2005.
52. Zhang Y, Lee TS, Kolb EM, Sun K, Lu X, Sladek FM, Kassab GS, Garland T Jr, Shyy JY. AMP-activated protein kinase is involved in endothelial NO synthase activation in response to shear stress. Arterioscler Thromb Vasc Biol 26: 1281-1287, 2006.